Assessment

• Assess patient for change in severity of HIV symptoms and for symptoms of opportunistic infections throughout therapy

• Assess patient for allergy to sulfonamides. May exhibit cross-sensitivity

• Assess patient for skin reactions throughout therapy Reactions may be severe and life threatening. Discontinue therapy if severe reactions or moderate rashes with systemic symptoms occur

• Monitor viral load and CD4 cell count regularly during therapy

• May cause increased serum glucose, cholesterol, and triglyceride levels

amprenavir is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.